# Clinical Evaluation of Metal Panel Allergens: Dose Response Study

> **NCT02615249** · PHASE2 · COMPLETED · sponsor: **Allerderm** · enrollment: 122 (actual)

## Conditions studied

- Dermatitis, Eczematous

## Interventions

- **BIOLOGICAL:** Metal Allergen Epicutaneous Patch

## Key facts

- **NCT ID:** NCT02615249
- **Lead sponsor:** Allerderm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-05
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615249, "Clinical Evaluation of Metal Panel Allergens: Dose Response Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02615249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*